Last updated on September 2018

A Phase II/III Study of High-dose Intermittent Sunitinib in Patients With Recurrent Glioblastoma Multiforme


Find a site near you

Start Over

University Medical Center Groningen

Groningen, Netherlands
2.28miles
  Connect »